Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 24, 2026
Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritis
Jinqi Liu, Yicong Li, Kai Fu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 17, 2018
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi, Maria Stepanova, Janus P Ong, et al.
Rheumatology and Therapy
|
March 3, 2023
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Arthritis Care & Research
|
May 23, 2023
Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept
Hermine I Brunner, Nikolay Tzaribachev, Ingrid Louw, et al.
The Journal of Rheumatology
|
April 17, 2018
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial
Mark C Genovese, César Pacheco-Tena, Arturo Covarrubias, et al.
The Journal of Rheumatology
|
January 16, 2021
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis
Nicolino Ruperto, Hermine I Brunner, Nikolay Tzaribachev, et al.
The Journal of Rheumatology
|
July 15, 2023
Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials
Nicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Arthritis Care & Research
|
January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study
Nicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 27, 2018
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease
Zobair M Younossi, Maria Stepanova, Janus Ong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 14, 2020
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States
Nicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 24, 2026
Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritis
Jinqi Liu, Yicong Li, Kai Fu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 17, 2018
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi, Maria Stepanova, Janus P Ong, et al.
Rheumatology and Therapy
|
March 3, 2023
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, et al.
Arthritis Care & Research
|
May 23, 2023
Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept
Hermine I Brunner, Nikolay Tzaribachev, Ingrid Louw, et al.
The Journal of Rheumatology
|
April 17, 2018
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial
Mark C Genovese, César Pacheco-Tena, Arturo Covarrubias, et al.
The Journal of Rheumatology
|
January 16, 2021
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis
Nicolino Ruperto, Hermine I Brunner, Nikolay Tzaribachev, et al.
The Journal of Rheumatology
|
July 15, 2023
Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials
Nicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Arthritis Care & Research
|
January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study
Nicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 27, 2018
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease
Zobair M Younossi, Maria Stepanova, Janus Ong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 14, 2020
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States
Nicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, et al.
Page
of 8